Chronic inflammation as a manifestation of defects in immunoregulatory networks: Implications for novel therapies based on microbial products

Inflammopharmacology

Volumn 17, Issue 4, 2009, Pages 193-203

  Bottasso, O ^a   Docena, G ^b   Stanford, J L ^c   Grange, J M ^c  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmunity; Cancer; Hygiene hypothesis; Immune regulation; Immunopathology; Infection; Inflammation; Metabolism

Indexed keywords

ALLERGY; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL FUNCTION; CELL STRESS; CHRONIC DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYGIENE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; MALIGNANT TRANSFORMATION; METABOLISM; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; TH17 CELL; TISSUE INJURY; TISSUE REPAIR; VASCULAR DISEASE;

ANIMALS; AUTOIMMUNITY; BIOLOGICAL PRODUCTS; CHRONIC DISEASE; DENDRITIC CELLS; DISEASE PROGRESSION; HUMANS; INFECTION; INFLAMMATION;

EID: 69049098778     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-009-0008-x     Document Type: Review

References (94)

1. EV Acosta-Rodriguez G Napolitani A Lanzavecchia et al. 2007 Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 8 942 949
2. N Adapala MM Chan 2008 Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model Lab Invest 88 1329 1339
3. P Allavena A Sica C Garlanda A Mantovani 2008 The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance Immunol Rev 222 155 161
4. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545
5. C Basset J Holton R O'Mahony I Roitt 2003 Innate immunity and pathogen-host interaction Vaccine 21 Suppl 2 S12 S23
6. JS Beckman WH Koppenol 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 C1424 C1437
7. SJ Bensinger P Tontonoz 2008 Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 454 470 477
8. E Bettelli Y Carrier W Gao et al. 2006 Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 235 238
9. SK Biswas A Sica CE Lewis 2008 Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms J Immunol 180 2011 2017
10. C Bonneaud J Mauc G Gonzalez et al. 2003 Assessing the cost of mounting an immune response Am Nat 161 367 379
11. O Bottasso ML Bay H Besedovsky A del Rey 2009 Immunoendocrine alterations during human tuberculosis as an integrated view of disease pathology Neuroimmunomodulation 16 68 77
12. A Castrillo SB Joseph SA Vaidya et al. 2003 Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism Mol Cell 12 805 816
13. J Condeelis JW Pollard 2006 Macrophages: obligate partners for tumor cell migration, invasion and metastasis Cell 124 263 266
14. DJ Conrad H Kuhn M Mulkins et al. 1992 Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase Proc Natl Acad Sci USA 89 217 221
15. SL Constant JL Brogdon DA Piggott et al. 2002 Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ J Clin Invest 110 1441 1448
16. DN Cook DS Pisetsky DA Schwartz 2004 Toll-like receptors in the pathogenesis of human disease Nat Immunol 5 975 979
17. A Cooke 2006 Th17 cells in inflammatory conditions Rev Diabet Stud 3 72 75
18. N Cools P Ponsaerts VF Van Tendeloo ZN Berneman 2007 Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells J Leukoc Biol 82 1365 1374
19. P Dandona A Aljada A Bandyopadhyay 2004 Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 4 7
20. D Dlugovitzky O Bottasso JC Dominino et al. 1999 Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172) Respir Med 93 557 562
21. E Doz S Rose J Nigou et al. 2007 Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan J Biol Chem 282 26014 26025
22. W Eder W Klimecki L Yu et al. 2004 Toll-like receptor 2 as a major gene for asthma in children of European farmers J Allergy Clin Immunol 113 482 488
23. KR Feingold C Grunfeld 1992 Role of cytokines in inducing hyperlipidemia Diabetes 41 Suppl 2 97 101
24. PEM Fine 1995 Variation in protection by BCG. Implications of and for heterologous immunity Lancet 346 1339 1345
25. LA Fouser JF Wright K Dunussi-Joannopoulos M Collins 2008 Th17 cytokines and their emerging roles in inflammation and autoimmunity Immunol Rev 226 87 102
26. S Gordon 2003 Alternative activation of macrophages Nat Rev Immunol 3 23 35
27. P Gosset AS Charbonnier P Delerive et al. 2001 Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells Eur J Immunol 31 2857 2865
28. JM Grange JL Stanford 1990 BCG vaccination and cancer Tubercle 71 61 64
29. MF Gregor GS Hotamisligil 2007 Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease J Lipid Res 48 1905 1914
30. C Guiducci AP Vicari S Sangaletti et al. 2005 Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection Cancer Res 65 3437 3446
31. U Hobohm JL Stanford JM Grange 2008 Pathogen associated molecular pattern in cancer immunotherapy Crit Rev Immunol 28 95 107
32. C Hong P Tontonoz 2008 Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors Curr Opin Genet Dev 18 461 467
33. GS Hotamisligil NS Shargill BM Spiegelman 1993 Adipose tissue expression of tumor necrosis factor alpha: direct role in obesity-linked insulin resistance Science 259 87 90
34. J Huang JS Welch M Ricote et al. 1999 Interleukin-4-dependent production of PPARγ ligand in macrophages by 12/15-lipoxygenase Nature 400 378 382
35. KJ Ishii S Koyama A Nakagawa et al. 2008 Host innate immune receptors and beyond: making sense of microbial infections Cell Host Microbe 3 352 363
36. N Ito H Nakamura Y Tanaka S Ohgi 1999 Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry Cancer 85 2359 2367
37. A Iwasaki R Medzhitov 2004 Toll-like receptor control of the adaptive immune responses Nat Immunol 5 987 995
38. AG Jarnicki J Lysaght S Todryk KH Mills 2006 Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+-regulatory T cells J Immunol 177 896 904
39. SB Joseph MN Bradley A Castrillo et al. 2004 LXR-dependent gene expression is important for macrophage survival and the innate immune response Cell 119 299 309
40. W Karmaus C Botezan 2002 Does a higher number of siblings protect against the development of allergy and asthma? A review J Epidemiol Community Health 56 209 217
41. SA Khader JE Pearl K Sakamoto et al. 2005 IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available J Immunol 175 788 795
42. SA Khader GK Bell JE Pearl et al. 2007 IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nat Immunol 8 369 377
43. H Korf S Vander Beken M Romano et al. 2009 Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice J Clin Invest 119 1626 1637
44. B Krone KF Kölmel JM Grange et al. 2003 Impact of vaccinations and infectious diseases on melanoma risk: evaluation of an EORTC case-control study Eur J Cancer 39 2372 2378
45. B Krone KF Kölmel BM Henz JM Grange 2005 Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control Eur J Cancer 41 104 117
46. Krone B, Oeffner F, Grange JM (2009) Is the risk of multiple sclerosis related to the 'biography' of the immune system? J Neurol 256 (Epub ahead of print)
47. W Liao X Li M Mancini L Chan 2006 Proteasome inhibition induces differential heat shock protein response but not unfolded protein response in HepG2 cells J Cell Biochem 99 1085 1095
48. X Ma PA Buffler S Selvin et al. 2002 Daycare attendance and risk of childhood acute lymphoblastic leukamia Br J Cancer 86 1419 1424
49. K Magnus 1966 Epidemiological basis of tuberculosis eradication. 3. Risk of pulmonary tuberculosis after human and bovine infections Bull World Health Organ 35 483 508
50. PR Mangan LE Harrington DB O'Quinn et al. 2006 Transforming growth factor-beta induces development of the T(H)17 lineage Nature 441 231 234
51. A Mantovani S Sozzani M Locati et al. 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 549 555
52. A Mantovani P Allavena A Sica B Balkwill 2008 Cancer-related inflammation Nature 454 436 444
53. FD Martinez PG Holt 1999 Role of microbial burden in aetiology of allergy and asthma Lancet 354 Suppl 2 12 15
54. P Matzinger 2002 The danger model: a renewed sense of self Science 296 301 305
55. R Medzhitov 2007 Recognition of microorganisms and activation of the immune response Nature 449 819 826
56. R Medzhitov 2008 Origin and physiological roles of inflammation Nature 454 428 435
57. Y Moret P Schmid-Hempel 2000 Survival for immunity: the price of immune system activation for bumblebee workers Science 290 1166 1168
58. GE Morris MK Whyte GF Martin et al. 2005 Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes Am J Respir Crit Care Med 15 814 822
59. A Mortellaro C Conforti-Andreoni J Fric P Ricciardi-Castagnoli 2008 Dendritic cells as sensors of environmental perturbations Microbes Infect 10 990 994
60. WK Nevala CM Vachon AA Leontovich et al. 2009 Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma Clin Cancer Res 15 1931 1939
61. JI Odegaard RR Ricardo-Gonzalez MH Goforth et al. 2007 Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 1116 1120
62. GS Palapattu S Sutcliffe PJ Bastian et al. 2005 Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis 26 1170 1181
63. F Perrillat J Clavel MF Auclerc et al. 2002 Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study Br J Cancer 86 1064 1069
64. AD Pradhan JE Manson N Rifai et al. 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327 334
65. B Pulendran 2005 Variegation of the immune response with dendritic cells and pathogen recognition receptors J Immunol 174 2457 2465
66. GA Rook 1991 Mobilising the appropriate T-cell subset: the immune response as taxonomist? Tubercle 72 253 254
67. Rook GA Zumla A 2001 Advances in the immunopathogenesis of pulmonary tuberculosis Curr Opin Pulm Med 7 116 121
68. GA Rook R Hernandez-Pando SL Lightman 1994 Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance Immunol Today 15 301 303
69. GA Rook V Adams J Hunt et al. 2004 Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders Springer Semin Immunopathol 25 237 255
70. H Ruan HF Lodish 2003 Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha Cytokine Growth Factor Rev 14 447 455
71. S Rutella S Danese G Leone 2006 Tolerogenic dendritic cells: cytokine modulation comes of age Blood 108 1435 1440
72. DT Rutkowski RJ Kaufman 2007 That which does not kill me makes me stronger: adapting to chronic ER stress Trends Biochem Sci 32 469 476
73. MI Schmidt BB Duncan AR Sharrett et al. 1999 Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study Lancet 353 1649 1652
74. TJ Scriba D Kalsdorf DA Abrahams et al. 2008 Distinct specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response J Immunol 180 1962 1970
75. JJ Senn PJ Klover IA Nowak et al. 2003 Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes J Biol Chem 278 13740 13746
76. A Sher E Pearce P Kaye 2003 Shaping the immune response to parasites: role of dendritic cells Curr Opin Immunol 15 421 429
77. A Sica T Schioppa A Mantovani P Allavena 2006 Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 717 727
78. G Soong B Reddy S Sokol et al. 2004 TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells J Clin Invest 113 1482 1489
79. Stanford JL, Stanford CA, Grange JM (2001) Environmental echoes. Sci Prog 84 Part 2:105-24
80. RM Steinman H Hemmi 2006 Dendritic cells: translating innate to adaptive immunity Curr Top Microbiol Immunol 311 17 58
81. DP Strachan 1989 Hay fever, hygiene, and household size BMJ 299 1259 1260
82. CM Tato DJ Cua 2008 Reconciling id, ego, and superego within interleukin-23 Immunol Rev 226 103 111
83. B Thorand H Lowel A Schneider et al. 2003 C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998 Arch Intern Med 163 93 99
84. ME Trujillo MJ Lee S Sullivan et al. 2006 Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase J Clin Endocrinol Metab 91 1484 1490
85. KT Uysal SM Wiesbrock MW Marino GS Hotamisligil 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-function Nature 389 610 614
86. Van Ginderachter JA, Movahedi K, Van den Bossche J, De Baetselier P (2008) Macrophages, PPARs, and Cancer. PPAR Res 2008:169414
87. FA Verreck T de Boer DM Langenberg et al. 2004 Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria Proc Natl Acad Sci USA 101 4560 4565
88. AP Vicari C Caux G Trinchieri 2002 Tumour escape from immune surveillance through dendritic cell inactivation Semin Cancer Biol 12 33 42
89. NJ Wilson K Boniface JR Chan et al. 2007 Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 950 957
90. H Xu GT Barnes Q Yang et al. 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 1821 1830
91. XY Yang LH Wang K Mihalic et al. 2002 Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor-γ activated by macrophage-derived 12/15-lipoxygenase ligands J Biol Chem 277 3973 3978
92. F Zandbergen J Plutzky 2007 PPARalpha in atherosclerosis and inflammation Biochim Biophys Acta 1771 972 982
93. J Zeromski I Mozer-Lisewska M Kaczmarek 2008 Significance of toll-like receptors expression in tumor growth and spreading: a short review Cancer Microenviron 1 37 42
94. K Zhang RJ Kaufman 2008 From endoplasmic reticulum stress to the inflammatory response Nature 454 455 462